• Je něco špatně v tomto záznamu ?

Automated Noncontact Ultrasound Imaging and Ablation System for the Treatment of Atrial Fibrillation: Outcomes of the First-in-Human VALUE Trial

MK. Turagam, J. Petru, P. Neuzil, K. Kakita, S. Kralovec, D. Harari, P. Phillips, D. Piazza, W. Whang, SR. Dukkipati, VY. Reddy,

. 2020 ; 13 (3) : e007917. [pub] 20200212

Jazyk angličtina Země Spojené státy americké

Typ dokumentu klinická studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025160

BACKGROUND: Catheter ablation for atrial fibrillation (AF) using point-by-point radiofrequency energy or single-application one-shot balloons is either technically challenging or have limited ability to accommodate variable patient anatomy to achieve acute and durable pulmonary vein (PV) isolation. A novel ablation system employs low intensity collimated ultrasound (LICU)-guided anatomic mapping and robotic ablation to isolate PVs. In this first-in-human, single-center, multioperator trial, VALUE trial (VytronUS Ablation System for Treatment of Paroxysmal Atrial Fibrillation; NCT03639597) in patients with paroxysmal atrial fibrillation, this LICU system was evaluated to determine its safety, effectiveness in PV isolation, and freedom from recurrent atrial arrhythmias. METHODS: In the enrolled 52 patients with paroxysmal atrial fibrillation, ultrasound M-mode-based left atrial anatomies were successfully created, and ablation was performed under robotic control along an operator-defined lesion path. The LICU system software advanced over the course of the study: the last 13 patients were ablated with enhanced software. RESULTS: Acute PV isolation was achieved in 98% of PVs-using LICU-only in 77.3% (153/198) of PVs and requiring touch-up with a standard radiofrequency ablation catheter in 22.7% (45/198) PVs. The touch-up rate decreased to 5.8% (3/52) in patients undergoing LICU-ablation with enhanced software. Freedom from atrial arrhythmia recurrence was 79.6% (39/49 patients) at 12 months or 92.3% (12/13 patients) with the enhanced software. Major adverse events occurred in 3 patients (5.8%): one had transient diaphragmatic paralysis, one vascular access complication, and one had transient ST-segment elevation from air-embolism, without sequelae. CONCLUSIONS: In this first-in-human study, low- intensity collimated ultrasound-guided anatomic mapping and robotic ablation allows PV isolation with good chronic safety; PV isolation success is improving with device enhancements. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03639597.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025160
003      
CZ-PrNML
005      
20201222155105.0
007      
ta
008      
201125s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/CIRCEP.119.007917 $2 doi
035    __
$a (PubMed)32078362
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Turagam, Mohit K $u Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, NY (M.K.T., W.W., S.R.D., V.Y.R.).
245    10
$a Automated Noncontact Ultrasound Imaging and Ablation System for the Treatment of Atrial Fibrillation: Outcomes of the First-in-Human VALUE Trial / $c MK. Turagam, J. Petru, P. Neuzil, K. Kakita, S. Kralovec, D. Harari, P. Phillips, D. Piazza, W. Whang, SR. Dukkipati, VY. Reddy,
520    9_
$a BACKGROUND: Catheter ablation for atrial fibrillation (AF) using point-by-point radiofrequency energy or single-application one-shot balloons is either technically challenging or have limited ability to accommodate variable patient anatomy to achieve acute and durable pulmonary vein (PV) isolation. A novel ablation system employs low intensity collimated ultrasound (LICU)-guided anatomic mapping and robotic ablation to isolate PVs. In this first-in-human, single-center, multioperator trial, VALUE trial (VytronUS Ablation System for Treatment of Paroxysmal Atrial Fibrillation; NCT03639597) in patients with paroxysmal atrial fibrillation, this LICU system was evaluated to determine its safety, effectiveness in PV isolation, and freedom from recurrent atrial arrhythmias. METHODS: In the enrolled 52 patients with paroxysmal atrial fibrillation, ultrasound M-mode-based left atrial anatomies were successfully created, and ablation was performed under robotic control along an operator-defined lesion path. The LICU system software advanced over the course of the study: the last 13 patients were ablated with enhanced software. RESULTS: Acute PV isolation was achieved in 98% of PVs-using LICU-only in 77.3% (153/198) of PVs and requiring touch-up with a standard radiofrequency ablation catheter in 22.7% (45/198) PVs. The touch-up rate decreased to 5.8% (3/52) in patients undergoing LICU-ablation with enhanced software. Freedom from atrial arrhythmia recurrence was 79.6% (39/49 patients) at 12 months or 92.3% (12/13 patients) with the enhanced software. Major adverse events occurred in 3 patients (5.8%): one had transient diaphragmatic paralysis, one vascular access complication, and one had transient ST-segment elevation from air-embolism, without sequelae. CONCLUSIONS: In this first-in-human study, low- intensity collimated ultrasound-guided anatomic mapping and robotic ablation allows PV isolation with good chronic safety; PV isolation success is improving with device enhancements. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03639597.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a fibrilace síní $x diagnóza $x patofyziologie $x chirurgie $7 D001281
650    _2
$a katetrizační ablace $x přístrojové vybavení $7 D017115
650    _2
$a design vybavení $7 D004867
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a převodní systém srdeční $x diagnostické zobrazování $x patofyziologie $7 D006329
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a venae pulmonales $x diagnostické zobrazování $x chirurgie $7 D011667
650    _2
$a recidiva $7 D012008
650    _2
$a chirurgie s pomocí počítače $x metody $7 D025321
650    _2
$a výsledek terapie $7 D016896
650    _2
$a ultrasonografie $x přístrojové vybavení $7 D014463
650    _2
$a mladý dospělý $7 D055815
655    _2
$a klinická studie $7 D000068397
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Petru, Jan $u Department of Cardiology, Homolka Hospital, Prague, Czech Republic (J.P., P.N., K.K., S.K., V.Y.R.).
700    1_
$a Neuzil, Petr $u Department of Cardiology, Homolka Hospital, Prague, Czech Republic (J.P., P.N., K.K., S.K., V.Y.R.).
700    1_
$a Kakita, Ken $u Department of Cardiology, Homolka Hospital, Prague, Czech Republic (J.P., P.N., K.K., S.K., V.Y.R.).
700    1_
$a Kralovec, Stepan $u Department of Cardiology, Homolka Hospital, Prague, Czech Republic (J.P., P.N., K.K., S.K., V.Y.R.).
700    1_
$a Harari, David $u VytronUS, Inc, Sunnyvale, CA (D.H., P.P., D.P.).
700    1_
$a Phillips, Patrick $u VytronUS, Inc, Sunnyvale, CA (D.H., P.P., D.P.).
700    1_
$a Piazza, Danielo $u VytronUS, Inc, Sunnyvale, CA (D.H., P.P., D.P.).
700    1_
$a Whang, William $u Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, NY (M.K.T., W.W., S.R.D., V.Y.R.).
700    1_
$a Dukkipati, Srinivas R $u Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, NY (M.K.T., W.W., S.R.D., V.Y.R.).
700    1_
$a Reddy, Vivek Y $u Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, NY (M.K.T., W.W., S.R.D., V.Y.R.). Department of Cardiology, Homolka Hospital, Prague, Czech Republic (J.P., P.N., K.K., S.K., V.Y.R.).
773    0_
$w MED00159578 $t Circulation. Arrhythmia and electrophysiology $x 1941-3084 $g Roč. 13, č. 3 (2020), s. e007917
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32078362 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222155101 $b ABA008
999    __
$a ok $b bmc $g 1599305 $s 1115846
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 13 $c 3 $d e007917 $e 20200212 $i 1941-3084 $m Circulation. Arrhythmia and electrophysiology $n Circ Arrhythm Electrophysiol $x MED00159578
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace